Tenaya Therapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€1.79M - Gross profit
-€1.79M - SG&A expenses
€20.09M - R&D expenses
€66.48M - EBITDA
-€82.29M - D&A
€5.38M - EBIT
-€88.36M - Interest expenses
€0.00 - EBT
-€85.47M - Tax expenses
€0.00 - Net income
-€85.47M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€5.27M - Changes in working capital
€3.90M - Operating cash flow
-€66.02M - Capex
€783.35K - Other investing cash flow
€10.30K - Net investing cash flow
€26.85M - Total cash dividends paid
€0.00 - Issuance of common stock
€41.37M - Debt repayment
€0.00 - Other financing cash flow
€1.19M - Net financing cash flow
€43.06M - Foreign exchange effects
€0.00 - Net change in cash
€3.89M - Cash at end of period
€54.13M - Free cash flow
-€65.24M
Balance sheet
- Cash and cash equivalents
€53.77M - Cash and short-term investments
€61.49M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€3.61M - Total current assets
€65.10M - Property, plant & equipment
€36.01M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€359.50K - Other non-current assets
€3.34M - Total non-current assets
€39.70M - Total assets
€104.81M - Accounts payable
€2.83M - Short-term debt
€2.43M - Other current liabilities
€5.60M - Total current liabilities
€10.86M - Long-term debt
€16.09M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€251.39K - Total non-current liabilities
€8.30M - Total liabilities
€19.15M - Common stock
€13.73K - Retained earnings
-€484.39M - Other equity
-€858.00 - Total equity
€85.65M - Total liabilities and shareholders' equity
€104.81M
Company information
- Market capitalization
€84.58M - Employees
97 - Enterprise Value
€61.94M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-99.8% Much better than peer group: -145.0% - ROA
-
-81.6% Much worse than peer group: -60.0% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-79.0% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€881.15K